---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-020457"
form_type: "8-K"
ticker: "SRXH"
cik: "0001471727"
company_name: "SRx Health Solutions, Inc."
filed_at: "2025-10-31T23:59:59+00:00"
generated_at: "2026-05-17T01:05:56.434278+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# SRx Health raises $15.23M in first closing of Series A preferred offering; secures up to $1B equity commitment

## Summary
- First closing of private placement: 19,035 Series A Preferred shares and 54.5M warrants for $15.23M; additional closings at investor option up to $30.46M total.
- Amendment to July 2025 Purchase Agreement increased total commitment from $50M to $1B; issued $20M convertible promissory note in connection.
- Series A Preferred conversion price fixed at $0.6109; warrants exercisable at $0.6109; company seeks stockholder approval to raise authorized common from 200M to 5B shares.
- Directors Lionel F. Conacher and David Allen White resigned Oct 31, 2025; committees reconstituted with Michael Young, Simon Conway and Joshua A. Epstein.

## SEC filing metadata
- accession: 0001493152-25-020457
- form_type: 8-K
- ticker: SRXH
- cik: 0001471727
- company_name: SRx Health Solutions, Inc.
- filed_at: 2025-10-31T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 5.02, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1471727/000149315225020457/0001493152-25-020457-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1471727/000149315225020457/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-020457
- JSON: https://secwatch.observer/filing/0001493152-25-020457.json
- Plain text: https://secwatch.observer/filing/0001493152-25-020457.txt

## Key facts
- Debt Financings
  SRx Health Solutions, Inc. amended credit facility of from $50 million to $1 billion with Investor.
  - Instrument: credit facility
  - Principal: from $50 million to $1 billion
  - Counterparty: Investor
  - Event: amendment
  source text: greement (the “Securities Purchase Agreement”) with certain accredited investors named therein. Pursuant to the Securities Purchase Agreement, up to 38,070 shares of the Company’s Series A convertible preferred stock, par value
  evidence_url: https://www.sec.gov/Archives/edgar/data/1471727/000149315225020457/0001493152-25-020457-index.htm
- Debt Financings
  SRx Health Solutions, Inc. incurred convertible notes of $20 million with Investor.
  - Instrument: convertible notes
  - Principal: $20 million
  - Counterparty: Investor
  - Event: incurrence
  source text: the Company issued to Investor a convertible promissory note in the aggregate principal amount of $20 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1471727/000149315225020457/0001493152-25-020457-index.htm
- Equity Issuances
  SRx Health Solutions, Inc. issued 19,035 shares of the Series A Preferred Stock of preferred stock to certain accredited investors for aggregate proceeds of approximately $15.23 million.
  - Security: preferred stock
  - Shares: 19,035 shares of the Series A Preferred Stock
  - Purchaser: certain accredited investors
  - Consideration: aggregate proceeds of approximately $15.23 million
  source text: On October 31, 2025, pursuant to the Securities Purchase Agreement, the Company issued and sold, and certain investors purchased, in a private placement (the “Private Placement”): 19,035 shares of the Series A Preferred Stock and 54,527,811 Warrants to purchase shares of Common Stock for aggregate proceeds of approximately $15.23 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1471727/000149315225020457/0001493152-25-020457-index.htm
- Equity Issuances
  SRx Health Solutions, Inc. issued 54,527,811 Warrants to purchase shares of Common Stock of warrant to certain accredited investors for aggregate proceeds of approximately $15.23 million.
  - Security: warrant
  - Shares: 54,527,811 Warrants to purchase shares of Common Stock
  - Purchaser: certain accredited investors
  - Consideration: aggregate proceeds of approximately $15.23 million
  source text: On October 31, 2025, pursuant to the Securities Purchase Agreement, the Company issued and sold, and certain investors purchased, in a private placement (the “Private Placement”): 19,035 shares of the Series A Preferred Stock and 54,527,811 Warrants to purchase shares of Common Stock for aggregate proceeds of approximately $15.23 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1471727/000149315225020457/0001493152-25-020457-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.